CHINOOK THERAPEUTICS INC (KDNY) Stock Analyst Earnings Estimates
NASDAQ:KDNY - Nasdaq - US16961L1061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 830K -95.19% | 51.625M 6,119.88% | 6.128M -88.13% | 2.897M -52.73% | 13.277M 358.30% | 81.114M 510.94% | 192.59M 137.43% | 401.71M 108.58% | 688.21M 71.32% | 1.144B 66.23% | 1.761B 53.93% | |
| EBITDA YoY % growth | -53.31M 32.54% | -101.513M -90.42% | -179.984M -77.30% | -224.975M -25.00% | -275.066M -22.26% | -300.294M -9.17% | -51.771M 82.76% | 191.31M 469.53% | 401.69M 109.97% | 740.53M 84.35% | 1.248B 68.53% | |
| EBIT YoY % growth | -54.71M 34.81% | -106.265M -94.23% | -185.083M -74.17% | -246.708M -33.30% | -288.259M -16.84% | -259.447M 10.00% | -142.936M 44.91% | 4.165M 102.91% | 177.47M 4,160.98% | 663.14M 273.66% | 1.167B 75.98% | |
| Operating Margin | -6,591.57% | -205.84% | -3,020.28% | -8,515.97% | -2,171.11% | -319.86% | -74.22% | 1.04% | 25.79% | 57.97% | 66.27% | |
| EPS YoY % growth | -3.64 24.17% | -2.57 29.40% | -2.88 -12.06% | -3.27 -13.68% | -3.52 -7.52% | -2.83 19.56% | -1.52 46.24% | 0.59 138.53% | 3.72 533.62% | 7.94 113.73% | 13.82 74.06% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.83 0.26% | -0.79 12.37% | -0.80 5.56% | -0.84 10.26% | -0.87 -5.04% | -0.97 -23.58% | -0.78 3.43% | -0.78 8.10% | -0.74 14.37% | -0.69 28.83% |
| Revenue Q2Q % growth | 255K -89.80% | 272.544K -46.77% | -100.00% | -100.00% | -100.00% | 19.584M 7,085.63% | 2.059M | 4.12M | 10.299M | 16.479M -15.85% |
| EBITDA Q2Q % growth | -49.213M 8.61% | -49.962M 8.84% | -53.407M 11.16% | -58.797M 15.29% | -64.187M -30.43% | -67.537M -35.18% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -61.52M -6.66% | -63.123M -5.37% | -64.52M -5.05% | -68.227M 6.06% | -72.792M -18.32% | -84.22M -33.42% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.94 -54.10% | -0.83 | -0.11 | -13.35% |
| Q1 2023 Q2Q % growth | -0.85 -57.41% | -0.81 | -0.04 | -4.85% |
| Q4 2022 Q2Q % growth | -0.90 -742.86% | -0.81 | -0.09 | -11.69% |
| Q3 2022 Q2Q % growth | -0.83 -20.29% | -0.64 | -0.19 | -30.05% |
| Q2 2022 Q2Q % growth | -0.61 46.49% | -0.63 | 0.02 | 2.49% |
| Q1 2022 Q2Q % growth | -0.54 38.64% | -0.68 | 0.14 | 20.51% |
| Q4 2021 Q2Q % growth | 0.14 111.29% | -0.69 | 0.83 | 120.30% |
| Q3 2021 Q2Q % growth | -0.69 23.33% | -0.86 | 0.17 | 19.31% |
| Q2 2021 Q2Q % growth | -1.14 -8.57% | -0.80 | -0.34 | -42.68% |
| Q1 2021 Q2Q % growth | -0.88 -95.56% | -0.69 | -0.19 | -27.50% |
| Q4 2020 Q2Q % growth | -1.24 -3.33% | -0.45 | -0.79 | -173.19% |
| Q3 2020 Q2Q % growth | -0.90 10.00% | -0.46 | -0.44 | -93.92% |
| Q2 2020 Q2Q % growth | -1.05 8.70% | -0.97 | -0.08 | -8.36% |
| Q1 2020 Q2Q % growth | -0.45 68.97% | -0.69 | 0.24 | 34.64% |
| Q4 2019 Q2Q % growth | -1.20 | -1.07 | -0.13 | -11.69% |
| Q3 2019 Q2Q % growth | -1.00 | -1.18 | 0.18 | 15.36% |
| Q2 2019 Q2Q % growth | -1.15 | -0.93 | -0.22 | -23.67% |
| Q1 2019 Q2Q % growth | -1.45 | -0.97 | -0.48 | -49.87% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 1.008M 141.15% | 244.8K | 763.2K | 311.76% |
| Q1 2023 Q2Q % growth | 1.828M -32.22% | 244.8K | 1.583M | 646.73% |
| Q4 2022 Q2Q % growth | 512K -99.00% | 102K | 410K | 401.96% |
| Q3 2022 Q2Q % growth | 2.501M 62,425.00% | 102K | 2.399M | 2,351.96% |
| Q2 2022 Q2Q % growth | 418K 1,129.41% | 425.003K | -7.003K | -1.65% |
| Q1 2022 Q2Q % growth | 2.697M 670.57% | 2.697M | % | |
| Q4 2021 Q2Q % growth | 51.236M 327.92% | 51.236M | % | |
| Q3 2021 Q2Q % growth | 4K -99.89% | 42.503K | -38.503K | -90.59% |
| Q2 2021 Q2Q % growth | 34K -99.39% | 42.503K | -8.503K | -20.01% |
| Q1 2021 Q2Q % growth | 350K -97.49% | 51K | 299K | 586.27% |
| Q4 2020 Q2Q % growth | -22.48M -719.28% | 2.525M | -25.005M | -990.30% |
| Q3 2020 Q2Q % growth | 3.79M -21.04% | 3.91M | -120K | -3.07% |
| Q2 2020 Q2Q % growth | 5.57M 13.91% | 3.523M | 2.047M | 58.10% |
| Q1 2020 Q2Q % growth | 13.95M 254.06% | 10.705M | 3.245M | 30.31% |
| Q4 2019 Q2Q % growth | 3.63M | 4.684M | -1.054M | -22.50% |
| Q3 2019 Q2Q % growth | 4.8M | 4.118M | 682K | 16.56% |
| Q2 2019 Q2Q % growth | 4.89M | 10.27M | -5.38M | -52.39% |
| Q1 2019 Q2Q % growth | 3.94M | 9.037M | -5.097M | -56.40% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.05% | -0.34% | -0.34% |
| Revenue | 0% | 0% | 300.54% | 300.54% |